Dow Up 0.51% Nasdaq Up 0.24%

CTI BioPharma Corp. (CTIC)

-NasdaqCM
2.22 Up 0.05(2.30%) Nov 21, 4:00PM EST
|After Hours : 2.17 Down 0.05 (2.25%) Nov 21, 6:10PM EST
Prev Close:2.17
Open:2.21
Bid:2.12 x 1000
Ask:N/A
1y Target Est:5.50
Beta:1.64
Next Earnings Date:N/A
Day's Range:2.17 - 2.23
52wk Range:1.69 - 4.25
Volume:1,540,074
Avg Vol (3m):1,377,500
Market Cap:322.21M
P/E (ttm):N/A
EPS (ttm):-0.30
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for CTIC

Comparison

Symbol% ChgMkt Cap
CTICUp 2.30%322.21M
BMYUp 0.32%97.54B
RHHBYDown 1.04%253.38B
SNYUp 1.25%123.73B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):4.19
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.59
Quarterly EPS Est (Dec-14) :-0.17
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

CTI BioPharma Corp., a biopharmaceutical company, is engaged in the acquisition, development, and commercialization of treatments for cancer. It primarily focuses on the commercialization of PIXUVRI, an aza-anthracenedione derivative, which is in ... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback